{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:23:03Z","timestamp":1791390183057,"version":"4.3.3"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jacl.2025.03.002","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:27:27Z","timestamp":1741220847000},"page":"461-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Relationship between Helicobacter pylori and hypertriglyceridemia in the population"],"prefix":"10.1016","volume":"19","author":[{"given":"Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqian","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoli","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinshun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jacl.2025.03.002_bib0001","article-title":"Helicobacter pylori infection: current status and future prospects on diagnostic, therapeutic and control challenges","volume":"12","author":"Elbehiry","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"10.1016\/j.jacl.2025.03.002_bib0002","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12386","article-title":"Survival of Helicobacter pylori in gastric acidic territory","volume":"22","author":"Ansari","year":"2017","journal-title":"Helicobacter"},{"issue":"Pt 3","key":"10.1016\/j.jacl.2025.03.002_bib0003","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.semcancer.2021.09.014","article-title":"The interaction of Helicobacter pylori with cancer immunomodulatory stromal cells: new insight into gastric cancer pathogenesis","volume":"86","author":"Navashenaq","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10.1016\/j.jacl.2025.03.002_bib0004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection","volume":"9","author":"Malfertheiner","year":"2023","journal-title":"Nature Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.jacl.2025.03.002_bib0005","doi-asserted-by":"crossref","first-page":"e13030","DOI":"10.1111\/hel.13030","article-title":"Interactions between Helicobacter pylori infection and host metabolic homeostasis: a comprehensive review","volume":"28","author":"Ye","year":"2023","journal-title":"Helicobacter"},{"issue":"3","key":"10.1016\/j.jacl.2025.03.002_bib0006","doi-asserted-by":"crossref","first-page":"e12967","DOI":"10.1111\/hel.12967","article-title":"Helicobacter pylori infection and risk of cardiovascular disease","volume":"28","author":"Sun","year":"2023","journal-title":"Helicobacter"},{"issue":"11","key":"10.1016\/j.jacl.2025.03.002_bib0007","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00535-017-1337-y","article-title":"A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease","volume":"52","author":"Kim","year":"2017","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jacl.2025.03.002_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.972777","article-title":"Helicobacter pylori and unignorable extragastric diseases: mechanism and implications","volume":"13","author":"He","year":"2022","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.jacl.2025.03.002_bib0009","doi-asserted-by":"crossref","first-page":"e12636","DOI":"10.1111\/hel.12636","article-title":"Review: helicobacter pylori and extragastric diseases","volume":"24","author":"Franceschi","year":"2019","journal-title":"Helicobacter"},{"key":"10.1016\/j.jacl.2025.03.002_bib0010","article-title":"Is laryngeal squamous cell carcinoma related to Helicobacter pylori?","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.jacl.2025.03.002_bib0011","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s13238-020-00814-7","article-title":"The role of the gut microbiome and its metabolites in metabolic diseases","volume":"12","author":"Wu","year":"2021","journal-title":"Protein Cell"},{"issue":"2","key":"10.1016\/j.jacl.2025.03.002_bib0012","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacl.2025.03.002_bib0013","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3389\/fendo.2020.00616","article-title":"Hypertriglyceridemia-causes, significance, and approaches to therapy","volume":"11","author":"Santos-Baez","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"10.1016\/j.jacl.2025.03.002_bib0014","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11883-021-00962-z","article-title":"Clinical management of hypertriglyceridemia in the prevention of cardiovascular disease and pancreatitis","volume":"23","author":"Hernandez","year":"2021","journal-title":"Curr Atheroscler Rep"},{"issue":"8","key":"10.1016\/j.jacl.2025.03.002_bib0015","first-page":"559","article-title":"Trends in lipids level and dyslipidemia among Chinese adults, 2002-2015","volume":"32","author":"Song","year":"2019","journal-title":"Biomed Environ Sci: BES"},{"key":"10.1016\/j.jacl.2025.03.002_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanwpc.2023.100809","article-title":"Trends in major non-communicable diseases and related risk factors in China 2002-2019: an analysis of nationally representative survey data","volume":"43","author":"Peng","year":"2024","journal-title":"Lancet Regional Health Western Pacific"},{"issue":"7","key":"10.1016\/j.jacl.2025.03.002_bib0017","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/1751-2980.12367","article-title":"Association between Helicobacter pylori infection and metabolic syndrome: a systematic review and meta-analysis","volume":"17","author":"Upala","year":"2016","journal-title":"J Dig Dis"},{"issue":"11","key":"10.1016\/j.jacl.2025.03.002_bib0018","article-title":"Helicobacter pylori (H. pylori) infection-associated dyslipidemia in the Asir region of Saudi Arabia","volume":"13","author":"Izhari","year":"2023","journal-title":"Life (Basel)"},{"issue":"12","key":"10.1016\/j.jacl.2025.03.002_bib0019","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1111\/j.1572-0241.2008.02151.x","article-title":"Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population","volume":"103","author":"Gunji","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"7138","key":"10.1016\/j.jacl.2025.03.002_bib0020","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1136\/bmj.316.7138.1130","article-title":"Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies","volume":"316","author":"Danesh","year":"1998","journal-title":"BMJ (Clin Res ed)"},{"issue":"2","key":"10.1016\/j.jacl.2025.03.002_bib0021","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/MEG.0000000000000774","article-title":"Effects of Helicobacter pylori eradication on insulin resistance and metabolic parameters: a systematic review and meta-analysis","volume":"29","author":"Upala","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.jacl.2025.03.002_bib0022","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1007\/s10620-005-2764-9","article-title":"Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels?","volume":"50","author":"Kanbay","year":"2005","journal-title":"Dig Dis Sci"},{"issue":"8","key":"10.1016\/j.jacl.2025.03.002_bib0023","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10046","key":"10.1016\/j.jacl.2025.03.002_bib0024","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","article-title":"Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents","volume":"388","author":"Di Angelantonio","year":"2016","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.jacl.2025.03.002_bib0025","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"49","key":"10.1016\/j.jacl.2025.03.002_bib0026","first-page":"825","article-title":"The diagnosis and treatment of hypertriglyceridemia","volume":"116","author":"Parhofer","year":"2019","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"10.1016\/j.jacl.2025.03.002_bib0027","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jacl.2025.03.002_bib0028","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jacc.2007.10.038","article-title":"Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial","volume":"51","author":"Miller","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jacl.2025.03.002_bib0029","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S2468-1253(23)00070-5","article-title":"Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis","volume":"8","author":"Li","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jacl.2025.03.002_bib0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.arteri.2020.04.001","article-title":"Prevalence of hypertriglyceridemia in adults and related cardiometabolic factors. SIMETAP-HTG study","volume":"32","author":"Ruiz-Garc\u00eda","year":"2020","journal-title":"Clinica e investigacion en arteriosclerosis"},{"issue":"18","key":"10.1016\/j.jacl.2025.03.002_bib0031","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.3748\/wjg.v20.i18.5226","article-title":"Metabolic consequences of Helicobacter pylori infection and eradication","volume":"20","author":"Buz\u00e1s","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.jacl.2025.03.002_bib0032","doi-asserted-by":"crossref","first-page":"1917s","DOI":"10.1093\/jn\/127.9.1917S","article-title":"Potential role of TNFalpha and lipoprotein lipase as candidate genes for obesity","volume":"127","author":"Kern","year":"1997","journal-title":"J Nutr"},{"issue":"12","key":"10.1016\/j.jacl.2025.03.002_bib0033","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jclinpath-2021-207719","article-title":"Hypertriglyceridaemia: an update","volume":"75","author":"Wierzbicki","year":"2022","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.jacl.2025.03.002_bib0034","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof","year":"2013","journal-title":"Physiol Rev"},{"issue":"5","key":"10.1016\/j.jacl.2025.03.002_bib0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1523-5378.2009.00705.x","article-title":"Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population","volume":"14","author":"Gunji","year":"2009","journal-title":"Helicobacter"},{"issue":"1","key":"10.1016\/j.jacl.2025.03.002_bib0036","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12929-018-0469-6","article-title":"H. pylori infection and extra-gastroduodenal diseases","volume":"25","author":"Tsay","year":"2018","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.jacl.2025.03.002_bib0037","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13098-021-00765-x","article-title":"Association of Helicobacter pylori infection with the risk of metabolic syndrome and insulin resistance: an updated systematic review and meta-analysis","volume":"13","author":"Azami","year":"2021","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"10.1016\/j.jacl.2025.03.002_bib0038","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/SMJ.0b013e3181cf373f","article-title":"Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation","volume":"103","author":"Gen","year":"2010","journal-title":"South Med J"},{"key":"10.1016\/j.jacl.2025.03.002_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1285754","article-title":"Infection with Helicobacter pylori may predispose to atherosclerosis: role of inflammation and thickening of intima-media of carotid arteries","volume":"14","author":"Aramouni","year":"2023","journal-title":"Front Pharmacol"},{"issue":"42","key":"10.1016\/j.jacl.2025.03.002_bib0040","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.3748\/wjg.v12.i42.6865","article-title":"Insulin resistance in H pylori infection and its association with oxidative stress","volume":"12","author":"Aslan","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jacl.2025.03.002_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1909459","article-title":"The interplay between Helicobacter pylori and gastrointestinal microbiota","volume":"13","author":"Chen","year":"2021","journal-title":"Gut microbes"},{"issue":"7","key":"10.1016\/j.jacl.2025.03.002_bib0042","article-title":"Helicobacter pylori and the human gastrointestinal microbiota: a multifaceted relationship","volume":"13","author":"Tohumcu","year":"2024","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"10.1016\/j.jacl.2025.03.002_bib0043","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.14309\/ajg.0000000000002730","article-title":"Role of the intestine and its gut microbiota in metabolic syndrome and obesity","volume":"119","author":"Busch","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jacl.2025.03.002_bib0044","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3164\/jcbn.17-88","article-title":"Effects of Helicobacter pylori eradication on serum lipid levels","volume":"62","author":"Adachi","year":"2018","journal-title":"J Clin Biochem Nutr"},{"issue":"10","key":"10.1016\/j.jacl.2025.03.002_bib0045","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1473-3099(19)30272-5","article-title":"Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial","volume":"19","author":"Liou","year":"2019","journal-title":"Lancet Infect Dis"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425000546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425000546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T07:32:57Z","timestamp":1750663977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425000546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1933287425000546"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.03.002","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between Helicobacter pylori and hypertriglyceridemia in the population","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}